Oracle's stock surges on cloud growth outlook despite earnings miss, as its $455 billion backlog and ambitious AI-driven expansion plans captivate investors.
Young Texas Democrat James Talarico enters Senate race, vowing to challenge political establishment and billionaire influence in the state.
Novartis to acquire US biotech Tourmaline Bio for $1.4B, bolstering its cardiovascular pipeline with a promising anti-inflammatory drug candidate.
Oracle's stock surges on cloud growth outlook despite earnings miss, as its $455 billion backlog and ambitious AI-driven expansion plans captivate investors.
Young Texas Democrat James Talarico enters Senate race, vowing to challenge political establishment and billionaire influence in the state.
Novartis to acquire US biotech Tourmaline Bio for $1.4B, bolstering its cardiovascular pipeline with a promising anti-inflammatory drug candidate.